Vaxart, Inc. - Common Stock (VXRT)

Vaxart Inc is a biotechnology company focused on developing oral vaccines based on its proprietary platform technology

The company aims to create innovative vaccines that are not only effective but also easy to administer, eliminating the need for needles. Vaxart's research and development primarily targets infectious diseases, with a particular emphasis on creating solutions for viral infections and other public health challenges. Through its unique oral delivery system, Vaxart strives to enhance patient compliance and broaden access to vaccination, ultimately contributing to global health improvement.